NTRK1 and cancer: The increased PKM1 level in HLCS knockdown could attenuate cancer growth, as reported in prostate adenocarcinoma, where inhibiting receptor tyrosine kinase signaling induces the expression of PKM1 and attenuates the growth of glioblastoma (Yang et al., 2022).